top of page
  • White Facebook Icon
  • White Twitter Icon

M&A Transaction

Aug 6, 2024
1 min read

Updated: Sep 19, 2024

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd. (United Kingdom).


Pharma-Data specialises in Research and Development and development of Value-Added Medicinal Drug Products for Europe and USA. Rosemont is a leading developer, manufacturer and distributor of liquid medicines for over 50 years.


The acquisition complements Rosemont’s product development capability in house as well as improving Rosemont’s capability to develop other dosage forms and modified release oral liquids.


 
 
 

Recent Posts

See All
New Transparency Register

On 1 October 2026, the new Federal Act on the Transparency of Legal Entities and the Identification of Beneficial Owners will enter into force. For the first time, Switzerland is introducing a central

 
 
 
M&A Transaction

Scope Law advised the sellers on the parallel sale of two established Swiss hospitality companies as part of a succession solution. The two transactions were structured and executed simultaneously. Co

 
 
 
Financing Round

Scope Law advised SquaredData AG (ETFBOOK), Zurich, on its USD 13 million funding round led by Expedition Growth Capital, with participation from existing investor BlackFin Capital Partners. ETFBOOK i

 
 
 

Comments


bottom of page